Ernesto Alexis Barrera

Ernesto Alexis Barrera

Auto-generated profile, based on publicly available information

Ernesto Alexis Barrera

Department of Physiology, Universidad Autonoma de Nuevo Leon, School of Medicine, Av. Francisco I. Madero y Dr. Eduardo Aguirre Pequeño S/N.o, Col. Mitras Centro, 64460, Monterrey, Nuevo Leon, Mexico

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
CCCarlos Rodrigo Cámara
Carlos Rodrigo Cámara
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
EBErnesto Alexis Barrera
Ernesto Alexis Barrera
ACAndrés Jesús Cabello
Andrés Jesús Cabello
AGArmando Garcia
Armando Garcia
JAJesus Ancer
Jesus Ancer
Ketamine anesthesia reduces intestinal ischemia/reperfusion injury in rats

17 September 2014 in Journal of Brachial Plexus and Peripheral Nerve Injury
Verified
Journal Article
Open access
PDF file
CCCarlos R Cámara-Lemarroy
Carlos R Cámara-Lemarroy
FGFrancisco Javier Guzman-de la Garza
Francisco Javier Guzman-de la Garza
EBErnesto Barrera-Oranday
Ernesto Barrera-Oranday
ACAndrés J Cabello-García
Andrés J Cabello-García
AGArmando García-Tamez
Armando García-Tamez
NFNancy Fernández-Garza
Nancy Fernández-Garza
The inflammatory response appears to be essential in the modulation of the degeneration and regeneration process after peripheral nerve injury. In injured nerves, cyclooxygenase-2 (COX-2) is strongly upregulated around the injury site, possibly playing a role in the regulation of the inflammatory response. In this study we investigated the effect of celecoxib, a COX-2 inhibitor, on functional recovery after sciatic nerve crush in rats. Unilateral sciatic nerve crush injury was performed on 10 male Wistar rats. Animals on the experimental group (n = 5) received celecoxib (10 mg/kg ip) immediately before the crush injury and daily for 7 days after the injury. Control group (n = 5) received normal saline at equal regimen. A sham group (n = 5), where sciatic nerve was exposed but not crushed, was also evaluated. Functional recovery was then assessed by calculating the sciatic functional index (SFI) on days 0,1,7,14 and 21 in all groups, and registering the day of motor and walking onset. In comparison with control group, celecoxib treatment (experimental group) had significant beneficial effects on SFI, with a significantly better score on day 7. Anti-inflammatory drug celecoxib should be considered in the treatment of peripheral nerve injuries, but further studies are needed to explain the mechanism of its neuroprotective effects.